[STZ] Constellation Brands: Can Beer Growth Hold Its Margin?

Constellation Brands sells Mexican beer brands such as Modelo, Corona and Pacifico in the United States alongside a streamlined premium wine and spirits portfolio; its calendar schedules the FY2027 second quarter earnings call for 2026-10-05.[1] The latest quarter produced $2.433 billion of sales, down 3% as reported but up 3% organically, and $845 million of operating income; management also maintained FY2027 guidance for organic sales growth of -1% to +1%, Beer sales growth of -1% to +1%, and free cash flow of $1.6-$1.7 billion.[2]

Three issues matter most in the coming results. First, Beer depletions and shipments need to keep moving together because Q1 Beer sales and operating income each rose 2% after FY2026 depletions had fallen about 2%; second, the smaller Wine and Spirits business needs to turn 6.6% depletion growth into shipments, 8% organic sales growth and a 5%-6% margin; third, the roughly $800 million full-year capital-spending plan needs to support $1.6-$1.7 billion of free cash flow without creating a Mexico capacity or supply constraint.[2][3]

Company Background and Business Structure

Constellation Brands, founded in 1945, produces, imports and markets alcoholic beverages, but its economic center has shifted decisively toward high-end U.S. beer.[3] The company reports Beer, Wine and Spirits, and Corporate Operations and Other; Beer holds an exclusive perpetual license to produce the Mexican portfolio and import, market and sell it in the United States. FY2026 Beer sales were $8.3152 billion versus $823.8 million for Wine and Spirits, making Beer about 91% of the two operating segments' sales.[3]

Wine and Spirits now focuses on higher-end retained brands following the 2025 divestitures and relies on a concentrated U.S. wholesale distribution system.[3] Those sales make reported comparisons misleading: the prior-year first quarter included $142 million from brands that were later sold, so the 47% reported Q1 decline does not directly measure demand for the retained portfolio.[2]

Financial History and Current Position

Constellation Brands' annual sales first rose and then fell as disposals and weaker Beer demand changed the portfolio. Revenue increased from $8.822 billion in FY2022 to $10.208 billion in FY2025, then declined to $9.139 billion in FY2026; FY2026 operating income was $2.863 billion, net income attributable to CBI was $1.687 billion, operating cash flow was $2.7 billion and free cash flow was $1.8 billion.[3]

The latest quarter showed resilient profit and cash generation, though its revenue components need separate interpretation. FY2027 Q1 produced $2.433 billion of consolidated sales, $845 million of operating income and $653.8 million of net income, up 27% from $516.1 million; operating cash flow was $662 million, free cash flow was $485 million, and the company had repurchased $324 million of shares through June 2026.[2][4]

Operating Model

The revenue model begins with shipment volume multiplied by realized price and mix, while consumer depletions lead company shipments and distributor inventory can shift reported sales between quarters. Beer sales roughly equal shipments times price and package mix; organic Wine and Spirits sales also exclude divested brands and depend on retained-brand depletions becoming shipments within one or two quarters.[3]

The profit model depends on sales covering product, logistics, marketing and fixed production costs. Better Beer pricing and mix can raise revenue per unit, but aluminum tariffs and weak volume absorption can reduce margin; Wine and Spirits needs retained-brand mix and post-divestiture cost removal to convert organic growth into operating income.[2][3]

The cash model is direct: free cash flow equals operating cash flow less capital expenditures. Management plans FY2027 operating cash flow of $2.4-$2.5 billion, about $800 million of capex and $1.6-$1.7 billion of free cash flow; the company also announced a $100 million investment in U.S. farmers and its beer supply chain in August 2026, showing that lower major-project spending does not mean supply investment stops.[2][5]

Industry and Competitive Position

Constellation Brands' advantage in high-end U.S. beer comes from the scale, distribution and pricing of its Mexican import brands, but volume must validate that advantage. The company said Q1 Beer dollar sales outperformed the total category by nearly three percentage points in Circana U.S. tracked channels; that measure does not cover the full market, while economic pressure on core Hispanic consumers, aluminum tariffs and concentrated Mexico production still constrain sales and margin.[2][3]

The streamlined Wine and Spirits portfolio also outperformed its category in the tracked channels during Q1, but its evidence boundary is narrower. Divestitures changed the comparison base and distributor destocking can separate depletions from shipments, so organic sales, depletions, shipments and segment margin must be read together rather than using the 47% reported decline or one channel-share measure alone.[2][3]

Core Debates

Can beer demand stabilization translate into growth without sacrificing margin?

The Beer debate determines most of company sales and operating profit because the segment supplied about 91% of FY2026 sales across the two operating segments.[3] The current evidence cuts both ways: Q1 Beer sales and operating income each grew 2%, and tracked-channel performance led the category by nearly three percentage points, but FY2026 depletions had fallen about 2% and operating margin declined 170 basis points to 38.0%.[2][3]

The relevant test is whether depletions, shipments and margin improve together instead of price masking weak volume. Management guides to FY2027 Beer sales growth of -1% to +1% and a 37%-38% margin; two quarters of positive, aligned depletions and sales with margin at or above 38% would strengthen the current view, while flat or positive sales with margin persistently below 37% would show that tariffs and fixed-cost absorption are blocking profit conversion.[2]

Can the streamlined wine and spirits portfolio turn depletion growth into revenue and profit?

The Wine and Spirits question is not when reported revenue rebounds, but whether retained brands become sustainably profitable after distributor inventory reductions. Q1 reported sales fell 47% as disposed brands left the comparison, but organic sales grew 8% and depletions grew 6.6%; management guides to just -1% to +1% organic growth and a 5%-6% segment margin for FY2027.[2]

This transmission requires depletions to become shipments, price and mix to turn those shipments into organic sales, and the smaller portfolio to absorb its costs. Two quarters of aligned positive depletions, shipments and organic sales with margin of at least 5% would confirm the reset; depletion growth that never reaches shipments, or margin below 5% despite growth, would weaken it.[2][3]

Can free cash flow rise after the Mexico capex peak without compromising supply capacity?

Lower capital spending is the clearest bridge from operating profit to cash. FY2026 operating cash flow was $2.7 billion and free cash flow was $1.8 billion; Q1 produced $662 million and $485 million, respectively, while management retained its plan for roughly $800 million of capex and $1.6-$1.7 billion of free cash flow.[2][3]

Lower capex is constructive only if capacity, agricultural inputs and the supply chain do not become bottlenecks. Capex near plan, free cash flow of at least $1.6 billion and no material capacity delay would confirm the conversion; operating cash below $2.4 billion, capex materially above $800 million, or Mexico project and supply constraints that require catch-up spending would weaken it.[2][5]

Risks and Falsifiers

Consumer risk affects Beer and Wine and Spirits sales, operating income and working-capital conversion together. Continued economic uncertainty could let pricing support sales temporarily without improving volume; two consecutive quarters of positive consolidated organic sales driven by volume would weaken this risk.[2][3]

The Beer-specific risk is persistent pressure on demand for Modelo and Corona, with lower shipments amplifying fixed costs. Two quarters of positive Beer depletions and sales with margin of at least 38% would falsify a deteriorating demand-and-absorption view; persistent margin below 37% would show that sales stabilization is not reaching profit.[2][3]

The Wine risk is that retained-brand depletion growth proves temporary or distributor inventory adjustment keeps blocking shipments. Two quarters of aligned growth in depletions, shipments and organic sales with margin at 5% would weaken the risk; positive depletions without revenue and profit conversion would strengthen it.[2][3]

The cash-flow risk comes from concentrated Mexico production and supply constraints because cutting capex too early can require later catch-up investment. Capex near $800 million, free cash flow of at least $1.6 billion and no major capacity delay would falsify that concern; the $100 million investment in U.S. farmers and beer supply is an execution item to keep watching.[2][5]

What to Watch Next

• For Beer demand and margin, compare depletions and sales with the Q1 2% growth baseline and operating margin with FY2026's 38.0%; two aligned positive quarters with margin at least 38% strengthen the case, while persistent margin below 37% weakens it.[2][3]
• For Wine and Spirits, compare depletions with Q1's 6.6%, organic sales with 8%, and margin with the 5%-6% FY2027 range; two aligned positive quarters with margin at least 5% confirm conversion.[2]
• For cash, compare operating cash flow and free cash flow with Q1's $662 million and $485 million, and capex with the roughly $800 million annual plan; at least $1.6 billion of free cash flow without a major delay strengthens the view, while a shortfall or catch-up spending weakens it.[2]

Conclusion

Constellation Brands is driven chiefly by Beer depletions, shipment price and mix, and fixed-cost absorption, while Wine and Spirits is rebuilding scale and profitability after its disposals. Q1 sales of $2.433 billion and operating income of $845 million show resilient profit, but the central unresolved relationship is whether 2% Beer sales growth can coexist with sustained volume and a 37%-38% margin.[2]

No qualifying independent view published after the latest results was available to adjudicate these operating debates. The reviewed results were dominated by company announcements, automated earnings recaps, holdings changes, ratings and target-price roundups, so they cannot be presented as an external consensus.

The current understanding would strengthen if Beer depletions and sales grow together with margin at least 38%, Wine depletions convert into organic sales and margin of at least 5%, and the company delivers at least $1.6 billion of free cash flow on roughly $800 million of capex. Diverging volume and sales, segment margins below guidance, or capacity and supply constraints that force capex higher would weaken it.[2][3][5]

Sources

[1] STZ earnings calendar updated 2026-09-11 · 2026-09-11 · 8-K

[2] STZ FY2027 Q1 results · 2026-06-30 · 8-K · https://www.sec.gov/Archives/edgar/data/16918/000001691826000050/stz-20260630.htm

[3] STZ FY2026 10-K · 2026-04-22 · 10-K · https://www.sec.gov/Archives/edgar/data/16918/000001691826000011/stz-20260228.htm

[4] STZ FY2027 Q1 10-Q · 2026-07-01 · 10-Q · https://www.sec.gov/Archives/edgar/data/16918/000001691826000053/stz-20260531.htm

[5] STZ farmer supply investment · 2026-08-19 · 8-K · https://www.globenewswire.com/news-release/2026/08/19/3347995/0/en/constellation-brands-announces-100-million-investment-to-support-u-s-farmers.html